SWA
BSX icon

Stratos Wealth Advisors’s Boston Scientific BSX Stock Holding History

Stratos Wealth Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,677
Closed -$419K – 641
2026
Q1 		$419K Sell
6,677
-592
-8% -$47.4K 0.03% 421
2025
Q4 		$693K Sell
7,269
-887
-11% -$87K 0.03% 372
2025
Q3 		$796K Buy
8,156
+998
+14% +$103K 0.04% 363
2025
Q2 		$769K Buy
7,158
+778
+12% +$78.7K 0.04% 357
2025
Q1 		$644K Sell
6,380
-189
-3% -$19K 0.04% 385
2024
Q4 		$587K Buy
6,569
+150
+2% +$13.2K 0.03% 431
2024
Q3 		$538K Buy
6,419
+522
+9% +$41.1K 0.02% 484
2024
Q2 		$454K Buy
5,897
+2,341
+66% +$171K 0.02% 495
2024
Q1 		$244K Sell
3,556
-2,052
-37% -$132K 0.01% 589
2023
Q4 		$324K Buy
5,608
+833
+17% +$44.5K 0.02% 538
2023
Q3 		$252K Buy
+4,775
New +$250K 0.02% 573

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Stratos Wealth Advisors's BSX Position: Q2 2026 in Review

Stratos Wealth Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 6,677 shares — an estimated $419K sold.

Stratos Wealth Advisors first reported a position in BSX in Q3 2023 and held it in 11 quarters. The position peaked at $796K in Q3 2025. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Stratos Wealth Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Stratos Wealth Advisors sold 6,677 Boston Scientific shares in Q2 2026, an estimated $419K.
  • Stratos Wealth Advisors first reported a position in Boston Scientific in Q3 2023 and held it in 11 quarters.
  • Stratos Wealth Advisors's Boston Scientific position peaked at $796K in Q3 2025.
  • 1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Stratos Wealth Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.